tiletamine hydrochloride has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, Y; Ikehara, S; Kaneko, K; Okigaki, M; Shimo, T; Takaya, J; Taniuchi, S; Umezawa, K | 1 |
| Carmichael, PG | 1 |
2 other study(ies) available for tiletamine hydrochloride and Shock, Septic
| Article | Year |
|---|---|
Dehydroxymethylepoxyquinomicin (DHMEQ) can suppress tumour necrosis factor-α production in lipopolysaccharide-injected mice, resulting in rescuing mice from death in vivo.
Topics: Animals; Apoptosis; Benzamides; Cell Nucleus; Cell Proliferation; Cells, Cultured; Cyclohexanones; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Shock, Septic; Spleen; Tumor Necrosis Factor-alpha | 2011 |
Pennyroyal metabolites in human poisoning.
Topics: Abortifacient Agents, Nonsteroidal; Cyclohexanones; Diagnosis, Differential; Humans; Oils, Volatile; Plant Poisoning; Shock, Septic | 1997 |